David E. Lazar Files SC 13D for OpGen, Inc.
Ticker: CFOR · Form: SC 13D · Filed: Apr 1, 2024 · CIK: 1293818
| Field | Detail |
|---|---|
| Company | Opgen Inc (CFOR) |
| Form Type | SC 13D |
| Filed Date | Apr 1, 2024 |
| Risk Level | medium |
| Pages | 8 |
| Reading Time | 10 min |
| Key Dollar Amounts | $0.01, $200,000, $2,800,000, $1.00, $3,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: ownership-change, activist-filing, sec-filing
Related Tickers: OPGN
TL;DR
**LAZAR FILES 13D ON OPGEN - BIG SHIFT?**
AI Summary
David E. Lazar filed a Schedule 13D on March 25, 2024, reporting beneficial ownership of OpGen, Inc. common stock. The filing indicates a change in reporting as Lazar previously filed a Schedule 13G. The specific percentage of ownership and dollar amounts are not detailed in this excerpt.
Why It Matters
This filing signals a potential shift in significant ownership or strategy for OpGen, Inc., as a major shareholder transitions from a 13G to a 13D filing, which typically implies more active involvement or a larger stake.
Risk Assessment
Risk Level: medium — A Schedule 13D filing indicates a significant ownership stake and potential for activist involvement, which can introduce volatility and uncertainty for the company and its stock.
Key Players & Entities
- David E. Lazar (person) — Filing person reporting beneficial ownership
- OpGen, Inc. (company) — Subject company
- Schedule 13D (document) — Type of SEC filing
- Schedule 13G (document) — Previous filing type by Lazar
FAQ
What is the date of the event requiring this Schedule 13D filing?
The date of the event requiring this filing is March 25, 2024.
Who is the filing person for this Schedule 13D?
The filing person is David E. Lazar.
What is the name of the subject company?
The subject company is OpGen, Inc.
Why is David E. Lazar filing a Schedule 13D instead of a Schedule 13G?
The filing indicates that David E. Lazar has previously filed a Schedule 13G and is now filing a Schedule 13D, suggesting a change in circumstances or reporting requirements.
What is the business address of OpGen, Inc.?
The business address of OpGen, Inc. is 9717 Key West Avenue, Suite 100, Rockville, MD 20850.
Filing Stats: 2,411 words · 10 min read · ~8 pages · Grade level 13.6 · Accepted 2024-04-01 16:05:09
Key Financial Figures
- $0.01 — Inc . (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securiti
- $200,000 — y the Reporting Person is approximately $200,000. Pursuant to the SPA, the Reporting Per
- $2,800,000 — ares for an aggregate purchase price of $2,800,000, however the purchase of such additiona
- $1.00 — Series E Preferred Stock at a price of $1.00 per shares of Series E Preferred Stock
- $3,000,000 — tock for an aggregate purchase price of $3,000,000, subject to the conditions described be
- $2,600,000 — red Stock for a total purchase price of $2,600,000, subject to the conditions described be
Filing Documents
- opgen_sc13d.htm (SC 13D) — 51KB
- 0001829126-24-002093.txt ( ) — 52KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: April 1, 2024 /s/ David E. Lazar DAVID E. LAZAR 5